Explore scalable strategies for iPSC-derived islet differentiation using GMP-grade activin A and KGF to advance diabetes therapeutics.
Century Therapeutics, Inc. (IPSC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Century ...
Century Therapeutics Inc. Annual stock financials by MarketWatch. View the latest IPSC financial statements, income statements and financial ratios.
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Cellistic, a cell therapy platform provider that partners with therapeutic developers to ensure cell therapies can achieve their full potential, has ...
Evotec has reached a collaboration with Censo Biotechnologies, using the latter’s patient-derived induced pluripotent stem cells (iPSC) to expand its platform for drug discovery. Scientists get iPSCs ...
A multi-institutional group, including members of the Tau Consortium, unveiled a stem cell tool kit for scientists studying primary tauopathies. In the November 12 issue of Stem Cell Reports, ...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results